Bifidobacterium longum 30 capsules (3 billion CFU/capsule)

25.00

The use of Bifidobacterium longum probiotics in the treatment of chronic constipation, has shown favourable effects when combined with fructo-oligosaccharides (FOS) in weight loss interventions1, enhancing stool frequency, and reducing abdominal pain in patients with Irritable Bowel Syndrome (IBS) 2. Studies have shown that B. longum assists in repopulating the intestinal microbiota3, especially after a course of medication4 that eradicates the bacterial overgrowth. Combining B. longum with FOS has shown positive biochemical and neuropsychological results5  have also been seen with patients suffering from Minimal Hepatic Encephalopathy (MHE), and increases the Bifidobacteria population6 in permanent vegetative status (PVS) patients.

Description

Dosage: 3 billion CFU per capsule

Capsules per order: 30 capsules

Instructions: 1 capsule daily (morning)

Citations:

  1. Amenta M. et al. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). Acta Biomed 2006; 77(3):157-62. https://pubmed.ncbi.nlm.nih.gov/17312986/
  2. Colecchia A. et al. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study. Minerva Gastroenterol Dietol 2006; 52(4):349-58. https://pubmed.ncbi.nlm.nih.gov/17108864/
  3. Fanigliulo L. et al. Role of gut microflora and probiotic effects in the irritable bowel syndrome. Acta Biomed 2006; 77(2):85-9. https://pubmed.ncbi.nlm.nih.gov/17172187/
  4. Di Pierro F. et al. Effects of rifaximin-resistant Bifidobacterium longum W11 in subjects with symptomatic uncomplicated diverticular disease treated with rifaximin. Minerva Gastroenterol Dietol. 2019 Dec; 65(4):259-264. https://www.minervamedica.it/en/journals/gastroenterology/article.php?cod=R08Y2019N04A0259
  5. Malaguarnera M. et al. Bifidobacterium longum with fructo-oligosaccharides (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007; 52:3259-3265. https://pubmed.ncbi.nlm.nih.gov/17393330/
  6. Del Piano M. et al. Clinical Experience With Probiotics in the Elderly on Total Enteral Nutrition. J Clin Gastroenterol 2004;38:S111-S114. https://pubmed.ncbi.nlm.nih.gov/15220673/